Donald C. Blair

TL;DR: Stigma is associated with psychological adjustment and adherence difficulties and is experienced more commonly among people who disclose their HIV status to a broad range of social contacts and should be addressed in stress management, health promotion, and medication adherence interventions for HIV-positive people.

TL;DR: Results indicated that smoking was associated with more HIV-related symptoms, greater alcohol and marijuana use, and less social support, and psychosocial interventions targeting this population should consider the relationships between biopsychosocial factors and smoking behavior.

TL;DR: Elevated serum levels of soluble interleukin 2 receptors (SIL-2R) were detected in 73% of patients with acquired immunodeficiency syndrome, 80% of AIDS-related complex patients, 78% of anti-HIV-positive lymphadenopathy syndrome patients, 85% of HIV-antibody-positive hemophiliacs, and80% ofAnti-Hiv-positive asymptomatic homosexual males, iv drug abusers, and heterosexual contacts.

TL;DR: In a series of multivariate analyses that controlled for demographic and health status variables, benefit finding was associated with lower depression scores, greater social support, and more physical activity, but showed no association to HAART adherence or substance use.

TL;DR: Future smoking cessation interventions with this population should target medical adherence and depression as intervention components, andRegression analyses provided partial support for the hypothesis that depressive symptoms mediated nonadherence among smokers.